Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Deficiency in lipid peroxidation suppressor Gpx4 results in neonatal cataract formation in mice
Author Affiliations & Notes
  • Zongbo WEI
    Department of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States
  • Caili Hao
    Department of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States
  • Kazi Radeen
    Department of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States
  • Xingjun Fan
    Department of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States
  • Footnotes
    Commercial Relationships   Zongbo WEI None; Caili Hao None; Kazi Radeen None; Xingjun Fan None
  • Footnotes
    Support  NEI EY028158(XF) P30EY031631
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 970. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zongbo WEI, Caili Hao, Kazi Radeen, Xingjun Fan; Deficiency in lipid peroxidation suppressor Gpx4 results in neonatal cataract formation in mice. Invest. Ophthalmol. Vis. Sci. 2024;65(7):970.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Lens crystallins and lipids have extended lifespans with minimal turnover within the lens. The prolonged existence of these proteins and lipids makes them more prone to damage from oxidation. Age-related increases in lipid peroxidation have been observed in both human and mouse lenses. However, the precise role of lipid peroxidation in cataractogenesis remains unclear. In this study, we aim to investigate whether the deletion of lipid peroxidation suppressor GPX4 plays a role in the formation of cataract.

Methods : Gpx4 was genetically knocked out in human lens epithelial cells (FHL124) using CRISPR-Cas9 technology. Cataracts were evaluated using a slit lamp and darkfield microscopy. The lens epithelial cells were quantified through serial HE sections. Plasma membrane lipid peroxidation was assessed using immunofluorescent staining and lipidomics. Rescue experiments were conducted by treating Gpx4 knockout (KO) mice with liproxstatin-1. Cell viability was determined through a CCK8 assay, while lipid peroxidation was assessed using C11-Bodipy 581/591.

Results : In Vitro: Deletion of GPX4 in FHL124 cells led to a significant increase in cell membrane lipid oxidation, iron accumulation, and cell death. A lipid peroxidation inhibitor, liproxstatin-1 (Lip-1), was able to effectively rescue the cells from lipid peroxidation-induced cell death. Ex Vivo: RSL3, a potent GPX4 inhibitor, induced lipid oxidation and lens opacity in ex vivo cultured lenses, and could be prevented by (Lip-1). In Vivo: Lens-specific Gpx4 deletion was achieved using MLR10-Cre/Gpx4f/f, resulting in the observation of cataracts in mice at P0. These cataracts progressively worsened during postnatal lens development, eventually leading to microphthalmia in adult Gpx4 KO mice. Cell death was evident in the Gpx4 KO lenses, and further investigations revealed a significant increase in markers associated with ferroptosis rather than apoptosis. Interestingly, administering the ferroptosis inhibitor liproxstatin-1 via intraperitoneal injection before E12.5 effectively alleviated cataract formation in Gpx4 KO mice.

Conclusions : Our findings highlight the protective role of GPX4 against lipid oxidation, emphasizing that the lack of Gpx4 contributes to the formation of cataracts in mouse lenses. Managing lipid peroxidation emerges as a potential approach for averting the onset of cataracts.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×